297 related articles for article (PubMed ID: 27328415)
21. Reprogramming of human fibroblasts to induced pluripotent stem cells under xeno-free conditions.
Rodríguez-Pizà I; Richaud-Patin Y; Vassena R; González F; Barrero MJ; Veiga A; Raya A; Izpisúa Belmonte JC
Stem Cells; 2010 Jan; 28(1):36-44. PubMed ID: 19890879
[TBL] [Abstract][Full Text] [Related]
22. Generation of Induced Pluripotent Stem Cells from Human Epidermal Keratinocytes.
Yang YH; Zhang RZ; Cheng S; Xu B; Tian T; Shi HX; Xiao L; Chen RH
Cell Reprogram; 2018 Dec; 20(6):356-364. PubMed ID: 30388030
[TBL] [Abstract][Full Text] [Related]
23. Induction of pluripotency in long-term cryopreserved human neonatal fibroblasts in feeder-free condition.
Csobonyeiova M; Krajciova L; Nicodemou A; Polak S; Danisovic L
Cell Tissue Bank; 2017 Mar; 18(1):45-52. PubMed ID: 27873029
[TBL] [Abstract][Full Text] [Related]
24. Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells.
Zhou W; Freed CR
Stem Cells; 2009 Nov; 27(11):2667-74. PubMed ID: 19697349
[TBL] [Abstract][Full Text] [Related]
25. Rapid generation of secondary fibroblasts through teratoma formation.
Cho SM; Park JS; Min B; Kwon S; Kang YK
Biotechniques; 2015 Jul; 59(1):34-41. PubMed ID: 26156782
[TBL] [Abstract][Full Text] [Related]
26. Induced pluripotent stem cell lines derived from human gingival fibroblasts and periodontal ligament fibroblasts.
Wada N; Wang B; Lin NH; Laslett AL; Gronthos S; Bartold PM
J Periodontal Res; 2011 Aug; 46(4):438-47. PubMed ID: 21443752
[TBL] [Abstract][Full Text] [Related]
27. Improved methods for reprogramming human dermal fibroblasts using fluorescence activated cell sorting.
Kahler DJ; Ahmad FS; Ritz A; Hua H; Moroziewicz DN; Sproul AA; Dusenberry CR; Shang L; Paull D; Zimmer M; Weiss KA; Egli D; Noggle SA
PLoS One; 2013; 8(3):e59867. PubMed ID: 23555815
[TBL] [Abstract][Full Text] [Related]
28. Differentiation of human foreskin fibroblast-derived induced pluripotent stem cells into hepatocyte-like cells.
Wang J; Zhao P; Wan Z; Jin X; Cheng Y; Yan T; Qing S; Ding N; Xin S
Cell Biochem Funct; 2016 Oct; 34(7):475-482. PubMed ID: 27569862
[TBL] [Abstract][Full Text] [Related]
29. Generation of stable pluripotent stem cells from NOD mouse tail-tip fibroblasts.
Liu J; Ashton MP; Sumer H; O'Bryan MK; Brodnicki TC; Verma PJ
Diabetes; 2011 May; 60(5):1393-8. PubMed ID: 21464439
[TBL] [Abstract][Full Text] [Related]
30. Transgene-free iPSCs generated from small volume peripheral blood nonmobilized CD34+ cells.
Merling RK; Sweeney CL; Choi U; De Ravin SS; Myers TG; Otaizo-Carrasquero F; Pan J; Linton G; Chen L; Koontz S; Theobald NL; Malech HL
Blood; 2013 Apr; 121(14):e98-107. PubMed ID: 23386128
[TBL] [Abstract][Full Text] [Related]
31. Reprogramming of COPD lung fibroblasts through formation of induced pluripotent stem cells.
Basma H; Gunji Y; Iwasawa S; Nelson A; Farid M; Ikari J; Liu X; Wang X; Michalski J; Smith L; Iqbal J; El Behery R; West W; Yelamanchili S; Rennard D; Holz O; Mueller KC; Magnussen H; Rabe K; Castaldi PJ; Rennard SI
Am J Physiol Lung Cell Mol Physiol; 2014 Mar; 306(6):L552-65. PubMed ID: 24487392
[TBL] [Abstract][Full Text] [Related]
32. Reprogramming of somatic cells after fusion with induced pluripotent stem cells and nuclear transfer embryonic stem cells.
Sumer H; Jones KL; Liu J; Heffernan C; Tat PA; Upton KR; Verma PJ
Stem Cells Dev; 2010 Feb; 19(2):239-46. PubMed ID: 19637940
[TBL] [Abstract][Full Text] [Related]
33. Genetic background affects induced pluripotent stem cell generation.
Schnabel LV; Abratte CM; Schimenti JC; Southard TL; Fortier LA
Stem Cell Res Ther; 2012 Aug; 3(4):30. PubMed ID: 22862934
[TBL] [Abstract][Full Text] [Related]
34. Generation of MERRF patient-derived induced pluripotent stem cell line iMERRF-C7.
Liang D; Hu H; Xu T; Wang Y; Hu P; Xu Z
Stem Cell Res; 2016 Nov; 17(3):616-618. PubMed ID: 27934592
[TBL] [Abstract][Full Text] [Related]
35. mRNA Reprogramming of T8993G Leigh's Syndrome Fibroblast Cells to Create Induced Pluripotent Stem Cell Models for Mitochondrial Disorders.
Grace HE; Galdun P; Lesnefsky EJ; West FD; Iyer S
Stem Cells Dev; 2019 Jul; 28(13):846-859. PubMed ID: 31017045
[TBL] [Abstract][Full Text] [Related]
36. Differentiation of Sendai Virus-Reprogrammed iPSC into β Cells, Compared with Human Pancreatic Islets and Immortalized β Cell Line.
Pellegrini S; Manenti F; Chimienti R; Nano R; Ottoboni L; Ruffini F; Martino G; Ravassard P; Piemonti L; Sordi V
Cell Transplant; 2018 Oct; 27(10):1548-1560. PubMed ID: 30251567
[TBL] [Abstract][Full Text] [Related]
37. Reprogramming of Primary Human Cells to Induced Pluripotent Stem Cells Using Sendai Virus.
Draper JM; Vivian JL
Methods Mol Biol; 2020; 2066():217-234. PubMed ID: 31512220
[TBL] [Abstract][Full Text] [Related]
38. Integrative analysis of miRNA and mRNA paired expression profiling of primary fibroblast derived from diabetic foot ulcers reveals multiple impaired cellular functions.
Liang L; Stone RC; Stojadinovic O; Ramirez H; Pastar I; Maione AG; Smith A; Yanez V; Veves A; Kirsner RS; Garlick JA; Tomic-Canic M
Wound Repair Regen; 2016 Nov; 24(6):943-953. PubMed ID: 27607190
[TBL] [Abstract][Full Text] [Related]
39. Derivation and 97% Purification of Human Thyroid Cells From Dermal Fibroblasts.
Ma R; Shi R; Morshed SA; Latif R; Davies TF
Front Endocrinol (Lausanne); 2020; 11():446. PubMed ID: 32760346
[No Abstract] [Full Text] [Related]
40. Nuclear reprogramming with a non-integrating human RNA virus.
Driscoll CB; Tonne JM; El Khatib M; Cattaneo R; Ikeda Y; Devaux P
Stem Cell Res Ther; 2015 Mar; 6(1):48. PubMed ID: 25889591
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
